STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
STAAR Surgical (STAA) Tops Q4 EPS by 9c
February 26, 2020 4:14 PM ESTSTAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.12, $0.09 better than the analyst estimate of $0.03. Revenue for the quarter came in at $38.9 million versus the consensus estimate of $38.42 million.
Fourth Quarter 2019 Overview
Net Sales of $38.9 Million Up 25% from the Prior Year QuarterICL Sales of $33.3 Million Up 27% and Units Up 27% from the Prior Year QuarterGross Margin at 74.1% vs. 73.7% in the Prior Year QuarterNet Income of $0.14 per Share vs. Prior Year Quarter Net Income of $0.02 per ShareNet Income includes a $0.07 per Share tax benefit above the previously announced preliminary... More